User profiles for "author:Craig Hendrix"

Craig W. Hendrix

Professor of Medicine, Johns Hopkins University
Verified email at jhmi.edu
Cited by 38421

[HTML][HTML] Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

JM Baeten, D Donnell, P Ndase… - New England journal …, 2012 - Mass Medical Soc
Background Antiretroviral preexposure prophylaxis is a promising approach for preventing
human immunodeficiency virus type 1 (HIV-1) infection in heterosexual populations …

RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil …

PA Anton, RD Cranston, A Kashuba… - AIDS research and …, 2012 - liebertpub.com
This study was designed to assess the safety, acceptability, pharmacokinetic (PK), and
pharmacodynamic (PD) responses to rectal administration of tenofovir (TFV) 1% vaginally …

[HTML][HTML] Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

MC Thigpen, PM Kebaabetswe… - New England journal …, 2012 - Mass Medical Soc
Background Preexposure prophylaxis with antiretroviral agents has been shown to reduce
the transmission of human immunodeficiency virus (HIV) among men who have sex with …

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled …

K Choopanya, M Martin, P Suntharasamai, U Sangkum… - The Lancet, 2013 - thelancet.com
Background Antiretroviral pre-exposure prophylaxis reduces sexual transmission of HIV. We
assessed whether daily oral use of tenofovir disoproxil fumarate (tenofovir), an antiretroviral …

[HTML][HTML] Tenofovir-based preexposure prophylaxis for HIV infection among African women

JM Marrazzo, G Ramjee, BA Richardson… - … England Journal of …, 2015 - Mass Medical Soc
Background Reproductive-age women need effective interventions to prevent the
acquisition of human immunodeficiency virus type 1 (HIV-1) infection. Methods We …

[HTML][HTML] Cabotegravir for HIV prevention in cisgender men and transgender women

RJ Landovitz, D Donnell, ME Clement… - … England Journal of …, 2021 - Mass Medical Soc
Background Safe and effective long-acting injectable agents for preexposure prophylaxis
(PrEP) for human immunodeficiency virus (HIV) infection are needed to increase the options …

[HTML][HTML] Use of a vaginal ring containing dapivirine for HIV-1 prevention in women

JM Baeten, T Palanee-Phillips, ER Brown… - … England Journal of …, 2016 - Mass Medical Soc
Background Antiretroviral medications that are used as prophylaxis can prevent acquisition
of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among …

[HTML][HTML] Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

S Delany-Moretlwe, JP Hughes, P Bock, SG Ouma… - The Lancet, 2022 - thelancet.com
Background Oral pre-exposure prophylaxis has been introduced in more than 70 countries,
including many in sub-Saharan Africa, but women experience considerable barriers to daily …

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

CW Hendrix, C Flexner, RT MacFarland… - Antimicrobial agents …, 2000 - Am Soc Microbiol
ABSTRACT AMD-3100, a bicyclam, is a novel agent that uniquely inhibits the entry of
human immunodeficiency virus type 1 (HIV-1) into CD4+ T cells via selective blockade of the …

Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit

JB Dimick, RK Pelz, R Consunji, SM Swoboda… - Archives of …, 2001 - jamanetwork.com
Hypothesis Catheter-related bloodstream infection (CRBSI) in critically ill surgical patients
with prolonged intensive care unit (ICU) stays is associated with a significant increase in …